Reply

doi:10.1002/art.42500

Comment

. 2023 Sep;75(9):1679-1680.

doi: 10.1002/art.42500. Epub 2023 Jul 6.

Reply

Yu-Hsiu Chen¹, Xin Zhang², Virginia Byers Kraus³

Affiliations

¹ Duke Molecular Physiology Institute, Duke University, Durham, NC, Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan and Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Penghu Branch, Tri-Service General Hospital, Penghu, Taiwan.
² Duke Molecular Physiology Institute Duke University and Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC.
³ Duke Molecular Physiology Institute, Duke University, Department of Orthopaedic Surgery and Department of Medicine, Duke University School of Medicine, Durham, NC.

PMID: 36908027
PMCID: PMC10804421
DOI: 10.1002/art.42500

Comment

Reply

Yu-Hsiu Chen et al. Arthritis Rheumatol. 2023 Sep.

. 2023 Sep;75(9):1679-1680.

doi: 10.1002/art.42500. Epub 2023 Jul 6.

Authors

Yu-Hsiu Chen¹, Xin Zhang², Virginia Byers Kraus³

Affiliations

¹ Duke Molecular Physiology Institute, Duke University, Durham, NC, Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan and Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Penghu Branch, Tri-Service General Hospital, Penghu, Taiwan.
² Duke Molecular Physiology Institute Duke University and Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC.
³ Duke Molecular Physiology Institute, Duke University, Department of Orthopaedic Surgery and Department of Medicine, Duke University School of Medicine, Durham, NC.

PMID: 36908027
PMCID: PMC10804421
DOI: 10.1002/art.42500

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

All authors declare that there are no conflicts of interest associated with this study.

Comment on

Association of dipeptidylpeptidase 4 (CD26) with chondrocyte senescence and radiographic progression in knee osteoarthritis: comment on the article by Chen et al.
Huang AF, Xu WD. Huang AF, et al. Arthritis Rheumatol. 2023 Sep;75(9):1678-1679. doi: 10.1002/art.42490. Epub 2023 Jul 3. Arthritis Rheumatol. 2023. PMID: 36897805 No abstract available.

References

1. Chen Y-H, Zhang X, Chou C-H, Hsueh M-F, Attarian D, Li Y-J, et al. Dipeptidyl-Peptidase 4 (CD26) is Associated with Chondrocyte Senescence and Radiographic Progression in Knee Osteoarthritis. Arthritis & Rheumatology. - PMC - PubMed
1. Mohetaer M, Li G, Wang Y, Cao L. Protective effects of gemigliptin against type II collagen degradation in human chondrocytes. Biomedicine & Pharmacotherapy. 2018;104:590–4. - PubMed
1. Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, et al. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019;71(7):978–85. - PubMed
1. Wang K, Chen X, Chen Y, Sheng S, Huang Z. Grape seed procyanidins suppress the apoptosis and senescence of chondrocytes and ameliorates osteoarthritis via the DPP4-Sirt1 pathway. Food & Function. 2020;11(12):10493–505. - PubMed
1. Chen Z, Yu J, Fu M, Dong R, Yang Y, Luo J, et al. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway. Biochemical pharmacology. 2020;177:113951. - PubMed

Publication types

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources

[1] Chen Y-H, Zhang X, Chou C-H, Hsueh M-F, Attarian D, Li Y-J, et al. Dipeptidyl-Peptidase 4 (CD26) is Associated with Chondrocyte Senescence and Radiographic Progression in Knee Osteoarthritis. Arthritis & Rheumatology. - PMC - PubMed

[2] Chen Y-H, Zhang X, Chou C-H, Hsueh M-F, Attarian D, Li Y-J, et al. Dipeptidyl-Peptidase 4 (CD26) is Associated with Chondrocyte Senescence and Radiographic Progression in Knee Osteoarthritis. Arthritis & Rheumatology. - PMC - PubMed

[3] Mohetaer M, Li G, Wang Y, Cao L. Protective effects of gemigliptin against type II collagen degradation in human chondrocytes. Biomedicine & Pharmacotherapy. 2018;104:590–4. - PubMed

[4] Mohetaer M, Li G, Wang Y, Cao L. Protective effects of gemigliptin against type II collagen degradation in human chondrocytes. Biomedicine & Pharmacotherapy. 2018;104:590–4. - PubMed

[5] Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, et al. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019;71(7):978–85. - PubMed

[6] Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, et al. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019;71(7):978–85. - PubMed

[7] Wang K, Chen X, Chen Y, Sheng S, Huang Z. Grape seed procyanidins suppress the apoptosis and senescence of chondrocytes and ameliorates osteoarthritis via the DPP4-Sirt1 pathway. Food & Function. 2020;11(12):10493–505. - PubMed

[8] Wang K, Chen X, Chen Y, Sheng S, Huang Z. Grape seed procyanidins suppress the apoptosis and senescence of chondrocytes and ameliorates osteoarthritis via the DPP4-Sirt1 pathway. Food & Function. 2020;11(12):10493–505. - PubMed

[9] Chen Z, Yu J, Fu M, Dong R, Yang Y, Luo J, et al. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway. Biochemical pharmacology. 2020;177:113951. - PubMed

[10] Chen Z, Yu J, Fu M, Dong R, Yang Y, Luo J, et al. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway. Biochemical pharmacology. 2020;177:113951. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply

Affiliations

Reply

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources